MariMed executive converts 6,046 units into shares

The RSUs were granted on March 28, 2024, and the award agreement says the grant's remaining units vest in full on March 28, 2027.

Rhea-AI Filing Summary

At MariMed Inc., Chief Commercial Officer Ryan Crandall converted 6,046 RSUs into 6,046 common shares on September 28, 2026, on a one-for-one basis. The issuer withheld 2,095 common shares to satisfy tax withholding obligations, at a reported price of $0.077 per share. The reported RSU position following the transaction was 6,047 shares.

Insider Trade Summary

6,046 shares exercised/converted

Exercise 3 txns

Insider Crandall Ryan

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU) F1, F3	6,046	$0.00	$0.00
Exercise	Common stock F1	6,046	$0.00	$0.00
Tax Withholding	Common stock F2	2,095	$0.077	$161.32

Holdings After Transaction: Restricted Stock Units (RSU) — 6,047 contracts (Direct); Common stock — 1,128,197 shares (Direct)

Footnotes (3)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. F3. The RSUs were granted on March 28, 2024; the remaining RSUs under this grant will vest in full on March 28, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs converted: 6,046 RSUs Common shares acquired: 6,046 shares Shares withheld for tax obligations: 2,095 shares +4 more

7 metrics

RSUs converted 6,046 RSUs September 28, 2026; converted one-for-one into common shares

Common shares acquired 6,046 shares September 28, 2026

Shares withheld for tax obligations 2,095 shares Withheld by the issuer in connection with RSU vesting

Reported price per withheld share $0.077 per share Shares withheld for tax obligations

RSUs following transaction 6,047 RSUs Reported position following the September 28, 2026 transaction

RSU grant date March 28, 2024 Date the RSUs were granted

Remaining RSU vesting date March 28, 2027 The remaining RSUs under the grant vest in full

Key Terms

RSUs, tax withholding obligations, award agreement

3 terms

RSUs financial

"RSUs convert to shares of common stock on a one-for-one basis."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with the vesting of RSUs"

award agreement financial

"in accordance with the terms of an award agreement"

An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MRMD shares did Ryan Crandall receive from RSU conversion?

Ryan Crandall converted 6,046 RSUs into 6,046 shares of common stock on September 28, 2026, at the one-for-one conversion rate.

How many shares did MariMed withhold for Ryan Crandall's RSU taxes?

MariMed Inc. withheld 2,095 shares of common stock to satisfy tax withholding obligations in connection with RSU vesting; the reported price was $0.077 per share.

When were Ryan Crandall's RSUs granted, and when do the remaining RSUs vest?

The RSUs were granted on March 28, 2024. The remaining RSUs under the grant vest in full on March 28, 2027, in accordance with the award agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 04:15 PM Accepted by SEC EDGAR 09/28/2026 - 04:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Crandall Ryan

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD MASSACHUSETTS 02062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	09/28/2026		M		6,046	A	$0(1)	1,130,292	D
Common stock	09/28/2026		F		2,095(2)	D	$0.077	1,128,197	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	09/28/2026		M			6,046	(3)	(3)	Common Stock, par value $.001 per share	6,046	$0	6,047	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. The RSUs were granted on March 28, 2024; the remaining RSUs under this grant will vest in full on March 28, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Ryan Crandall	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)